- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-03
DOI
10.1007/s40262-019-00767-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
- (2018) David R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits
- (2018) Vidmantas Petraitis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline resistance genes are more prevalent in wet soils than in dry soils
- (2018) Yijun Kang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Concentration-dependent plasma protein binding: Expect the unexpected
- (2018) Roger L. Nation et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis
- (2018) Abrar K. Thabit et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
- (2018) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Multidrug-Resistant Enterobacteriaceae in Lebanese Hospital Wastewater: Implication in the One Health Concept
- (2018) Ziad Daoud et al. Microbial Drug Resistance
- Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
- (2018) Joseph V. Newman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mass Balance and Drug Interaction Potential of IV Eravacycline Administered to Healthy Subjects
- (2018) Joseph V. Newman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance
- (2018) Fan Zhang et al. BMC MICROBIOLOGY
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?
- (2018) Despoina Koulenti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: a retrospective matched cohort study
- (2018) Ayelet Raz-Pasteur et al. Journal of Global Antimicrobial Resistance
- The 21st-century challenge to neurocritical care: the rise of the superbug Acinetobacter baumannii. A meta-analysis of the role of intrathecal or intraventricular antimicrobial therapy in reduction of mortality
- (2017) Nasser Mohammed et al. Neurosurgical Focus
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Eravacycline Pharmacokinetics and Challenges in Defining Humanized ExposureIn Vivo
- (2016) Abrar K. Thabit et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of pan-resistance in KPC-2 carbapenemase-producingKlebsiella pneumoniaein Crete, Greece: a close call
- (2016) E. Bathoorn et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
- (2016) Joshua T. Thaden et al. Virulence
- Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis
- (2015) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
- (2014) Kevin P. Connors et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline for the treatment of intra-abdominal infections
- (2014) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More